Share:
Peer-Reviewed Publication
Virchows Arch2026August 25, 2026Journal Article

Basal crypt dysplasia in inflammatory bowel disease: morphological quandaries, p53 immunohistochemistry and diagnostic pointers.

Kristen M Stashek1, Runjan Chetty2,3
1Perelman School of Medicine, University of Philadelphia, Philadelphia, USA.
2Diagnexia Pty Ltd., Oxford, UK. Runjan.chetty@gmail.com.
3Diagnexia Laboratory, Building B, Langford Locks, Kidlington, Oxford, OX5 1LH, UK. Runjan.chetty@gmail.com.

Abstract

Basal crypt dysplasia (BCD) is among the most diagnostically challenging of the non-conventional dysplasia subtypes that arise in the setting of longstanding inflammatory bowel disease (IBD). Its defining characteristic, cytological atypia restricted to the basal compartment of the crypt with a deceptively bland surface epithelium, is contrary to the classical dictum that dysplasia invariably invo…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.